Patient groups are essential to understanding the value of medicines, but NICE must improve its disclosure practices for conflicts of interest to ensure credibility and impartiality, write Iva Parvanova, Arianna Gentilini, and colleagues
No takes yet. Share an insight, caveat, or question.
Parvanova et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: